All Stories

  1. The ESC Ethics Committee
  2. The need for specialized care for patients with Grown-up Congenital Heart Disease
  3. Valvular heart disease among non-valvular atrial fibrillation: a misnomer, in search of a new term
  4. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial